ClinVar Miner

Submissions for variant NM_000527.5(LDLR):c.1366C>T (p.Leu456Phe)

dbSNP: rs761004553
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 3
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
ClinGen Familial Hypercholesterolemia Variant Curation Expert Panel RCV004765348 SCV005375281 uncertain significance Hypercholesterolemia, familial, 1 2023-06-23 reviewed by expert panel curation The NM_000527.5 (LDLR):c. 1366C>T (p. Leu456Phe) variant is classified as Uncertain significance - insufficient evidence for Familial Hypercholesterolemia by applying ACMG/AMP evidence codes PM2 and BP4 as defined by the ClinGen Familial Hypercholesterolemia Expert Panel LDLR-specific variant curation guidelines (specification version 1.2) on 23 June 2023. The supporting evidence is as follows: PM2: PopMax MAF=0.00003 in South Asian population in gnomAD (gnomAD v2.1.1). BP4: REVEL=0.487, it is not above 0.75, splicing evaluation required. Functional data on splicing is not available. MES performed: A) Variant is not on limits. B) Variant is on limit but does not crate de novo AG. Variant created GT however is not on limit. C) Variant is on limit and nearby three intra-exonic AGs: cctcctgcctcagcacccAGc/ttt , Var/Wt cryptic score = 0.37/-0.2 = -0.15, it is <1.1; ctcagcacccagc/tttgacAGagc, Var/Wt cryptic score = -3.2/-2.9 = 1.103, it is = 1.1, however both scores are negative; and agcacccagc/tttgacagAGccc, Var/Wt cryptic score = -33.4/-34.48 = 0.97, it is <1.1. MES score for canonical intron 9 acceptor cttctctcctcctgcctcAGcac is 6.76, so none of the Var cryptic scores/Wt score is >0.9. Variant is not predicted to alter splicing and REVEL score is below 0.5, therefore BP4 is met.
Color Diagnostics, LLC DBA Color Health RCV001189133 SCV001356345 uncertain significance Familial hypercholesterolemia 2019-09-23 criteria provided, single submitter clinical testing This missense variant (also known as p.Leu435Phe in the mature protein) replaces leucine with phenylalanine at codon 456 of the LDLR protein. Computational prediction tool suggests that this variant may not impact protein structure and function (internally defined REVEL score threshold ≤0.5, PMID: 27666373). Splice site prediction tools suggest that this variant may not impact RNA splicing. To our knowledge, functional studies have not been performed for this variant. This variant has not been reported in individuals affected with familial hypercholesterolemia in the literature. This variant has been identified in 1/250830 chromosomes in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance.
Labcorp Genetics (formerly Invitae), Labcorp RCV001189133 SCV004612387 likely pathogenic Familial hypercholesterolemia 2023-05-14 criteria provided, single submitter clinical testing In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant disrupts the p.Leu456 amino acid residue in LDLR. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 19026292, 23064986). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt LDLR protein function. ClinVar contains an entry for this variant (Variation ID: 926526). This variant has not been reported in the literature in individuals affected with LDLR-related conditions. This variant is present in population databases (rs761004553, gnomAD 0.003%). This sequence change replaces leucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 456 of the LDLR protein (p.Leu456Phe).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.